Correlation of cutaneous sensitivity and cytokine response in children with asthma.

about

Correlation of cutaneous sensitivity and cytokine response in children with asthma.

Item

http://www.wikidata.org/entity/Q47119032

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Correlation of cutaneous sensitivity and cytokine response in children with asthma.

@en

Correlation of cutaneous sensitivity and cytokine response in children with asthma.

@nl

type

Item

label

Correlation of cutaneous sensitivity and cytokine response in children with asthma.

@en

Correlation of cutaneous sensitivity and cytokine response in children with asthma.

@nl

prefLabel

Correlation of cutaneous sensitivity and cytokine response in children with asthma.

@en

Correlation of cutaneous sensitivity and cytokine response in children with asthma.

@nl

P1476

Correlation of cutaneous sensitivity and cytokine response in children with asthma

@en

P2093

Amit Agarwal

http://www.w3.org/2001/XMLSchema#string

Bishnupada Chatterjee

http://www.w3.org/2001/XMLSchema#string

Meenu Singh

http://www.w3.org/2001/XMLSchema#string

Nandini Paul

http://www.w3.org/2001/XMLSchema#string

Rashmi Ranjan Das

http://www.w3.org/2001/XMLSchema#string

P2860

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

The immune response to intrinsic and extrinsic allergens: determinants of allergic disease.

Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Early life origins of asthma

Novel approaches and targets for treatment of chronic obstructive pulmonary disease.

Interleukin-17 regulation: an attractive therapeutic approach for asthma

Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma.

Immunomodulatory treatment strategies for allergic diseases.

Neutrophils, interleukin-17A and lung disease.

Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways.

P304

506-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/LUNGINDIA.LUNGINDIA_357_16

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anil Chauhan

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29098994

http://www.w3.org/2001/XMLSchema#string

P932

5684806

http://www.w3.org/2001/XMLSchema#string